GlobeNewswire Inc | Sep 9, 2020 08:00AM EDT

September 09, 2020

DALLAS and FORT WORTH, Texas, Sept. 09, 2020 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (Nasdaq: NEOS), a commercial-stage pharmaceutical company developing and manufacturing central nervous system-focused products, today announced that Jerry McLaughlin, President and Chief Executive Officer, will participate in a fireside chat at the Cantor Virtual Global Healthcare Conference on Wednesday, September 16, 2020, at 3:40 p.m. ET.

A live webcast of the fireside chat will be available on the Investor Relations page of the companys website at http://investors.neostx.com/. Following the presentation, a replay of the webcast will be available on Neos website for 30 days.

About Neos Therapeutics Neos Therapeutics, Inc.(NASDAQ: NEOS) is a commercial-stage pharmaceutical company developing and manufacturing central nervous system (CNS)-focused products. The Company markets Adzenys XR-ODT(amphetamine) extended-release orally disintegrating tablets (seeFull Prescribing Information, including Boxed WARNING), Cotempla XR-ODT(methylphenidate) extended-release orally disintegrating tablets (seeFull Prescribing Information, including Boxed WARNING), and Adzenys-ER(amphetamine) extended-release oral suspension (seeFull Prescribing Information, including Boxed WARNING), all for the treatment of ADHD. The Company also has a development candidate, NT0502, for the treatment of sialorrhea in patients with neurological conditions. Additional information about Neos is available atwww.neostx.com.

CONTACTS:

Richard I. EisenstadtChief Financial OfficerNeos Therapeutics(972) 408-1389reisenstadt@neostx.com

Sarah McCabe Investor Relations Stern Investor Relations, Inc. (212) 362-1200 sarah.mccabe@sternir.com